NP Life Sciences Health Industry Group Inc. income statement ACAT

In fiscal 2023, which ended Dec 31, 2023, NP Life Sciences Health Industry Group Inc. reported revenue of $164,621, up 61.4% from the year before. It recorded a net loss of $2,935. The operating loss came to $690, an operating margin of -0.4%. Diluted earnings per share were $0.00. Across the 5 fiscal years shown, revenue grew from $43,000 in fiscal 2019 to $164,621 in fiscal 2023, about 39.9% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
Revenue
0
+61.4%
0
+191.5%
0
+133.3%
0
-65.1%
0
Selling, general and administrative
0
+36.8%
0
+20.0%
0
-31.1%
0
-3.8%
0
Operating income
-0
+96.3%
-0
+71.3%
-0
+49.9%
-0
-20.4%
-0
Interest expense
0
—
—
—
—
Pretax income
-0
—
-0
+49.9%
-0
-20.4%
-0
Income tax
0
—
—
—
—
Net income
-0
+84.4%
-0
+71.3%
-0
+49.9%
-0
-20.4%
-0
Basic EPS
0.00
—
—
—
—
Diluted EPS
0.00
—
—
—
—
Weighted average shares, basic
43
+0.0%
43
—
—
—
Weighted average shares, diluted
43
—
—
—
—
Other measures
Interest coverage
-1.07x
—
—
—
—
Margins
Operating margin
-0.42%
-18.48%
-187.70%
-873.94%
-253.16%
Pretax margin
-0.81%
—
-187.69%
-873.77%
-253.09%
Profit margin
-1.78%
-18.49%
-187.69%
-873.77%
-253.09%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Services-Educational Services (SIC 8200)
Listed as
ACAT (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Danville, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1781726
Former names
GJ Culture Group US, Inc. (until Sep 29, 2022)

Other Services-Educational Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.